this puts SNTA at very oversold. dont sell your shares and add to this... CLDX took a dump too and see where.
it is. it seems it has to shake a few out before the rise up. Their drug will be approved or a director would NOT have bought 5 million shares of this company. buy on this dip price target at $16-19 a share.